N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma

NCT00295919 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: fenretinide lipid matrix
DRUG: ketoconazole
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

New Approaches to Neuroblastoma Therapy Consortium

Collaborators

[object Object]